medigraphic.com
SPANISH

Revista Médica de la Universidad Veracruzana

Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number S1

<< Back Next >>

Rev Med UV 2008; 8 (S1)

Polimorfismos de nucleótido unico (snp) en la región promotora de e-cadherina (cdh1) en pacientes jóvenes con cáncer gástrico

Ramos MA
Full text How to cite this article

Language: Spanish
References: 13
Page: 8-10
PDF size: 101.06 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Medina-Franco, H.; Heslin, MJ.; Cortés-González, R. “Clinicopathological characteristics of gastriccarcinoma in young andelderly patients: a comparative study”. Ann Surg Oncol 2000;7:515– 9.

  2. Ramos-De la Medina, A.; Salgado-Nesme, N.; Torres-Villalobos, G.; Medina-Franco, H. Clinicopathological characteristics of gastric cancer in a young patient population”. J Gastrointest Surg 2004; 8:240–4.

  3. Pignatelli, M.; Vessey, CJ. “Adhesion molecules: novel molecular tools in tumor pathology”. Hum Pathol 1994; 25:849–56.

  4. Takeichi, M. “The cadherins: cell-cell adhesion molecules controlling animal morphogenesis”. Development 1988; 102:639–55.

  5. Behrens, J.; Mareel, MM.; Von Roy, FM.; Birchmeier, W. “Dissectingtumor cell invasíon: epithelial cells acquire invasíveproperties after the loss of uvomorulin-mediated cell-celladhesion”. J Cell Biol 1989; 108:2435–47.

  6. Medina-Franco, H.; Gamboa-Dominguez, A.; Torres-Villalobos, G, et al. “Altered expression of E-cadherin predicts survival inyoung patients with poorly differentiated gastric adenocarcinoma”. Proc Am Soc Clin Oncol 2003; 22:351.

  7. Berx, G.; Becker, KF.; Hofler, H.; Van Roy, F. “Mutation of the human E-cadherin (CDH1) gene”. Hum Mutat 1998; 12:226–37.

  8. Guilford P, Hopkins J, Harraway J, et al.. Ecadherin germlinemutations in familial gastric cancer. Nature 1998; 392:402–5.

  9. Li, LC.; Chui, RM.; Sasaki, M. et al. “A single nucleotide polymorphismin the E-cadherin gene promoter alters transcriptional activities”. Cancer Res 2000; 60:873–6.

  10. Humar, B.; Graciano, F.; Cascinu, S. et al. “Association of CDH1 haplotypes with susceptibilityto sporadic diffuse gastric cancer”. Oncogene 2002; 21:8192–5.

  11. Ramos-De la Medina More, H.; Medina-Franco, H.; et al. “Singlenucleotide polymorphisms (SNPs) in the promoter region of CDH1 in familial gastric cancer”. Rev Esp Enferm Dig 2006;98:36–41.

  12. Wu, MS.; Huang, SP.; Chang, YT. et al. “Association of the 160C fi A promoter polymorphism of Ecadherin gene withgastric carcinoma risk”. Cancer 2002; 94:1443–8.

  13. Park, WS.; Cho, YG.; Park, JY. et al. “A single nucleotide polymorphismin the E-cadherin gene promoter )160 is not associated with risk of Korean gastric cancer”. J Korean Med




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med UV. 2008;8